Literature DB >> 4187022

Infection and iron overload in thalassemia.

L Caroline, P J Kozinn, F Feldman, F H Stiefel, H Lichtman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 4187022     DOI： 10.1111/j.1749-6632.1969.tb27784.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  8 in total

Review 1.  Immune cell functions in iron overload.

Authors:  M de Sousa
Journal:  Clin Exp Immunol       Date:  1989-01       Impact factor: 4.330

Review 2.  Iron and infection.

Authors:  E D Weinberg
Journal:  Microbiol Rev       Date:  1978-03

3.  Elevated polymorphonuclear phagocytic function in thalassemia patients by chemiluminescence.

Authors:  S S Deo; S M Merchant; A C Kapadia
Journal:  Indian J Pediatr       Date:  1994 Jul-Aug       Impact factor: 1.967

4.  Serum immunoglobulin concentrations before and after splenectomy in patients with homozygous beta-thalassaemia.

Authors:  M Constantoulakis; D Trichopoulos; O Avgoustaki; J Economidou
Journal:  J Clin Pathol       Date:  1978-06       Impact factor: 3.411

5.  The ferric enterobactin transporter Fep is required for persistent Salmonella enterica serovar typhimurium infection.

Authors:  Toni A Nagy; Sarah M Moreland; Helene Andrews-Polymenis; Corrella S Detweiler
Journal:  Infect Immun       Date:  2013-08-19       Impact factor: 3.441

6.  Immune functions in splenectomized thalassaemic children.

Authors:  J Ahluwalia; U Datta; R K Marwaha; S Sehgal
Journal:  Indian J Pediatr       Date:  2000-12       Impact factor: 1.967

7.  Inhibition of bacterial multiplication by the iron chelator deferoxamine: potentiating effect of ascorbic acid.

Authors:  B S van Asbeck; J H Marcelis; J J Marx; A Struyvenberg; J H van Kats; J Verhoef
Journal:  Eur J Clin Microbiol       Date:  1983-10       Impact factor: 3.267

8.  Resistance to infection in murine beta-thalassemia.

Authors:  N M Ampel; D B Van Wyck; M L Aguirre; D G Willis; R A Popp
Journal:  Infect Immun       Date:  1989-04       Impact factor: 3.441
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.